4 Shares To Buy On Market Dips: GlaxoSmithKline plc, SABMiller plc, Dignity Plc & Britvic Plc

A weak stock market could put quality firms on sale, such as GlaxoSmithKline plc (LON: GSK), SABMiller plc (LON: SAB), Dignity Plc (LON: DTY) and Britvic Plc (LON: BVIC)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When the stock market gets the wobbles, as recently, it’s usually a good time to focus in on quality firms.

Good-quality companies with consistent performance and attractive financial characteristics rarely sell cheaply, but periods of market weakness can provide an opportunity to buy the shares a little lower.

GlaxoSmithKline (LSE: GSK), SABMiller (LSE: SAB), Dignity (LSE: DTY) and Britvic (LSE: BVIC) are all firms with attractive underlying businesses and may be worth keeping an eye on for a decent entry point.

Pharmaceutical stalwart

With an update in May, pharmaceutical giant GlaxoSmithKline fleshed out what kind of growth we are likely to see from the firm. The directors expect revenue to increase at a compound annual growth rate in low-to-mid single digits from 2016 to 2020.

That signals potentially steady, if unspectacular expansion, which should power the company’s ability to keep its dividend payout progressing over the period. At today’s share price of 1347p or so, Glaxo’s forward dividend yield runs at around 6% with earnings covering the payout just once.

Low dividend cover seems to arise thanks to continued raising of the annual dividend in recent years despite falling earnings. With patent-expiry worries fading, we could see earnings rebuild over the period to 2020, but it seems a good idea to base any decision to invest in GlaxoSmithKline around the dynamics of the dividend payout.

Beer cash

Although SABMiller also grows slowly, the brewer’s cash-generating ability remains robust enabling a solid record of dividend advancement. Like pharmaceutical products, alcoholic beverages, based around often-loved beer brands, drive repeat purchasing and customer loyalty, making SABMiller something of a ‘defensive’ potential investment — often, our favourite tipple is the last expense to face the axe during austere times.

At a share price of 3354p, SABMiller’s dividend yield sits at about 2.3% for 2016 and the payout is covered a respectable twice by forward earnings. We find the strength here in the consistent record of rising dividends, powered by the firm’s gargantuan cash flow.

Business seems certain

Dignity is the UK’s only stock market listed provider of funeral-related services, and ongoing business seems more certain than in any other sector!

The firm acts as something of a consolidator to the industry, buying up undertaker operations as fast as it can. For example, back in May the firm said it had acquired 10 funeral locations since the start of the year, for an investment of approximately £8 million.

As you might imagine, cash flow is consistent and, on the back of that, the firm runs a large debt-load to fund its acquisition policy. However, over recent years a record of double-digit earnings growth presents as a thing of beauty.

There’s no denying Dignity’s ‘defensive’ nature, but at a share price of 2174p, the dividend yield sits at just 1.1% for 2016. That payout, however, is covered more than four-and-a-half times by forward earnings, suggesting the directors think the firm’s impressive growth has much further to run.

Cash-generating soft drinks

We find another consumer goods company in Britvic. This time, the firm’s focus is soft drinks and brands such as Robinsons, Tango, J2O and Fruit Shoot power that all-important cash flow thanks to customer loyalty and repeat purchasing.

There’s a long record of steady dividend progress — a dividend that rises annually is the greatest attraction of this kind of ‘defensive’ proposition, I reckon. At a share price of 730p the forward yield runs at around 3.4% for 2016 and forward earnings cover the payout more than twice.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has recommended Britvic and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »